PCR is the gold standard for diagnosing infectious diseases, but its complexity has kept it confined to centralized labs, out of reach for the patients and providers who need it most.
Transformative Biotech is changing that. Our patented direct-to-PCR platform technologies eliminate sample extraction entirely, and our @ANYWHERE™ handheld, smartphone-powered PCR testing platform is designed to bring rapid, accurate, and affordable molecular testing to anyone who needs it.
We’re proud to be taking that story to Vail this September as a selected presenting company at the 2026 Rocky Mountain Life Sciences Investor & Partnering Conference, hosted by Colorado BioScience Association, September 30-October 2 at the Grand Hyatt Vail.
If you’re attending, we’d love to connect. Reach out to our CEO Kevin Kraus to schedule time in Vail.
See you in Vail!
